SCINUS: A novel BIOreactor for SCAlablE universal cell therapy manufacturing
| Title | SCINUS: A novel BIOreactor for SCAlablE universal cell therapy manufacturing |
|---|---|
| Acronym | Bioscale |
| Start date | 2020-09-01 |
| End date | 2023-08-31 |
| Sponsor | European Commission |
Associated cell lines
Project Description
Cell therapy (CT), using cultured human cells, is a treatment option that holds great promise for curing a vast number of difficult-to-treat diseases, such as diabetes, Alzheimer's and ALS, and also for skin reconstruction or promoting recovery from an infarct. While cell therapies are currently moving into clinical practice, the production of cells on a commercial scale poses a major economic and industrial challenge. The new Eurostars project Bioscale will focus on the SCINUS expansion system, for cost-efficient cell culture, to achieve standardised CT production, ultimately leading to improved quality consistency in CT development and a reduced cost of CT commercialisation.